Retatrutide (30 mg) — Research Overview
This 30 mg format of Retatrutide is the high-capacity research vial of the leading triple-receptor agonist in metabolic and weight-loss peptide research in Canada. It is designed for laboratories running extended or multi-arm protocols.
Mechanism & Research Applications
Retatrutide is studied for simultaneous activation of GLP-1, GIP, and glucagon receptors — a combination researched for appetite regulation, insulin sensitivity, energy expenditure, and hepatic fat reduction. Its Phase II data has made it a focal point of next-generation metabolic research.
At 30 mg per vial, this format offers improved value per milligram over the 10 mg size and reduces vial count for larger studies.
Specifications
30 mg lyophilized powder per vial | ≥99% purity (HPLC-verified) | Batch-specific COA included
Quality & Sourcing in Canada
NuMe supplies Retatrutide (30 mg) as part of its catalogue of weight loss peptides in Canada, research peptides in Canada, and buy peptides in Canada. Every batch is verified to ≥99% purity by HPLC, ships domestically from within Canada (typically 1–3 business days), and includes a batch-specific Certificate of Analysis. Free shipping applies to orders over $300 CAD.
Frequently Asked Questions
Why choose the 30 mg Retatrutide?
The 30 mg vial offers better value per milligram and suits extended metabolic research protocols requiring more material. The compound is identical to the 10 mg format.
Is Retatrutide a research compound only?
Yes. It is an investigational triple-agonist supplied strictly for laboratory research — not approved for human use in Canada.
Does the 30 mg ship within Canada?
Yes, domestically with a batch-specific COA verifying ≥99% purity. For research use only.
For Research Purposes Only. This product is intended exclusively for laboratory research and in-vitro testing. It is not for human or veterinary use, consumption, or any therapeutic application.
Reviews
There are no reviews yet.